Brazil Enteral Nutrition Market Analysis & Forecast: 2026-2033
The Brazil Enteral Nutrition Market size is anticipated to grow at a CAGR of 7% with USD 380.3 Mn in 2026 and is expected to reach USD 609.2 Mn in 2033. The market is growing with the rising chronic disease burden, increasing cancer and stroke cases, expanding home healthcare services, growing hospital nutrition screening, and higher use of disease-specific formulas. According to IBGE, Brazil had 22.2 Mn people aged 65 years and above, representing 10.9% of the population, strengthening demand for clinical nutrition among elderly and chronically ill patients.
On the basis of protein composition, the standard protein diet segment accounts for the largest Brazil Enteral Nutrition Market share of 38.6% in 2026. The growth of the segment is mainly driven by the wide use as a first-line nutritional support option for patients with general malnutrition, inadequate oral intake, post-surgical recovery, elderly care needs, and chronic disease-related nutritional deficiency. Standard protein formulas are preferred because they provide balanced macro- and micronutrients and also can be used across hospital, home-care, as well as long-term care settings.
According to Danone Nutricia Brazil, Nutri Enteral Soya is a standard enteral and oral nutrition formula that is normocaloric and normoproteic, thereby supporting the broad clinical relevance of standard protein diets. A Brazilian hospital study published in 2025 found high malnutrition levels among patients receiving nutritional support, with 44.1% severely malnourished by SGA and 43.1% severely malnourished by GLIM, thereby strengthening the need for standard nutrition support.
On the basis of application, the nutrition source segment accounts for the largest Brazil Enteral Nutrition Market share of 58.4% in 2026. The growth of the segment is mainly driven by the increasing use of enteral nutrition as a complete or primary nutrition source for patients who are unable to meet their nutritional requirements through normal oral intake. This includes patients with cancer, swallowing difficulty, neurological disorders, critical illness, gastrointestinal conditions, and post-surgical recovery needs.
Fresenius Kabi Brazil states that enteral nutrition supplies nutrients through the digestive tract, either orally or through feeding tubes, and is indicated for patients with insufficient oral intake, swallowing difficulties, or increased nutritional requirements.
On the basis of distribution channel, the hospitals segment accounts for the largest Brazil Enteral Nutrition Market share of 48.2% in 2026. The segment’s growth is owing to the high patient flow, ICU admissions, cancer care, neurological cases, gastrointestinal surgeries, trauma, and prolonged hospital stays. Brazil has a large hospital ecosystem; according to the U.S. International Trade Administration, the country had 7,309 hospitals, 500,253 hospital beds, and 575,930 physicians in 2024.
Hospitals also remain the primary point of diagnosis for disease-related malnutrition. The classic Brazilian IBRANUTRI study found malnutrition in 48.1% of hospitalized patients, including 12.5% severe malnutrition, showing the high clinical relevance of nutrition therapy in inpatient care.
To learn more about this report, Request Free Sample
On the basis of packaging, the ready to drink segment accounts for the largest Brazil Enteral Nutrition Market share of 36.7% in 2026. The segment’s growth is owing to the convenience, dosing accuracy, reduced preparation time, lower contamination risk, and suitability for both hospital and home-care use. Ready-to-drink formats are especially useful for elderly patients, oncology patients, renal patients, and caregivers who require easy-to-administer nutritional products.
Nestle Health Science Brazil lists Nutren Control 200 ml as a ready-to-consume product containing 15 g of protein per 200 ml, with fibers, omega-3, vitamins, and minerals. Nestlé’s Novasource REN 200 ml is also listed as a modified formula for enteral and oral nutrition, with 1.5 kcal/ml energy density and 18 g protein per portion, supporting demand for compact ready-to-drink formats.
Brazil’s enteral nutrition demand is closely linked to aging, cancer, neurological conditions, gastrointestinal disorders, and post-surgical recovery. Elderly patients are more likely to experience dysphagia, frailty, sarcopenia, malnutrition, dementia, and chronic disease complications, all of which increase the need for oral nutritional supplements and tube-based feeding.
WHO states that the global population aged 60 years and above is expected to rise from 1.0 billion in 2020 to 1.4 billion by 2030 and 2.1 billion by 2050, indicating a structural rise in clinical nutrition needs worldwide. In Brazil, IBGE reported that the number of people aged 65 years and over grew 57.4% between 2010 and 2022, making aging one of the strongest long-term demand drivers.
This rising aging base supports higher demand for high-protein, fiber-enriched, diabetes-specific, renal-specific, and oncology nutrition formulas. In Brazil, the aging trend is expected to increase both hospital-based enteral nutrition use and long-term home enteral nutrition consumption.
Brazil’s clinical nutrition market is moving from basic caloric supplementation toward disease-specific, high-protein, fiber-enriched, peptide-based, and home-care-compatible products. This shift is important because hospitals and home-care programs increasingly need standardized formulas that can support malnourished, oncology, diabetic, neurological, and post-surgical patients. Enteral formulas are also being supported by clearer regulatory guidance. ANVISA lists standard enteral nutrition formulas, modified formulas, pediatric formulas, and enteral nutrition modules under RDC 21/2015, which creates a formal product classification structure for manufacturers and importers.
In June 2025, Nestlé Health Science Brazil presented nutrition solutions at Naturaltech 2025, one of Brazil’s major nutrition events, through an interactive stand focused on health and nutrition products. This development supports the wider professional and consumer awareness of specialized nutrition categories and strengthens the visibility of clinical nutrition brands in Brazil. Such company-led engagement is expected to support the adoption of enteral and oral nutritional solutions across hospitals, pharmacies, clinics, as well as home-care channels.
|
Current Event |
Description and its Impact |
|
Anvisa’s 2026 Regulatory Review of Foods for Medical Purposes |
|
|
RDC 976/2025 and IN 367/2025 Composition and Labeling Controls |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Some of the major key players in Brazil Enteral Nutrition Market are Abbott Laboratories, Prodiet Nutricao Clinica, Nestle S.A., Danone, Royal Friesland Campina, Baxter International Inc., Nutrimed, B. Braun Melsungen AG, Pfizer, Inc., Reckitt Benckiser Group plc, Eurofarma, Nuteral, Fresenius Kabi AG, and Nutricium.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 380.3 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7% | 2033 Value Projection: | USD 609.2 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Abbott Laboratories, Prodiet Nutrição Clínica, Nestlé S.A., Danone, Royal Friesland Campina, Baxter International Inc., Nutrimed, B. Braun Melsungen AG, Pfizer, Inc., Reckitt Benckiser Group plc, Eurofarma, Nuteral, Fresenius Kabi AG, and Nutricium. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Share
Share
Vipul Patil is a dynamic management consultant with 6 years of dedicated experience in the pharmaceutical industry. Known for his analytical acumen and strategic insight, Vipul has successfully partnered with pharmaceutical companies to enhance operational efficiency, cross broader expansion, and navigate the complexities of distribution in markets with high revenue potential.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
